Syzygium Polyanthum Reduced TNF-α and ADAM17 Protein Expression in Myocardial Infarction Rat Model

Refli Hasan1, Gontar Alamsyah Siregar1, Dharma Lindarto1

  • 1Department of Internal Medicine, School of Medicine, Universitas Sumatera Utara, Medan, Indonesia.

Abstract

Insights

Syzygium polyanthum extract reduced inflammatory tumor necrosis factor-alpha (TNF-α) and ADAM17 expression in a myocardial infarction (MI) rat model, showcasing its anti-inflammatory potential.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Traditional Medicine

Background:

  • Myocardial infarction (MI) involves inflammatory cytokines like tumor necrosis factor-alpha (TNF-α), whose activity is regulated by ADAM17.
  • Syzygium polyanthum (SPE) is a traditional remedy in Southeast Asia with potential therapeutic applications.

Purpose of the Study:

  • To investigate the impact of Syzygium polyanthum extract on TNF-α and ADAM17 expression in a rat model of MI.
  • To elucidate the anti-inflammatory mechanisms of SPE in the context of cardiac injury.

Main Methods:

  • Myocardial infarction was induced in Wistar rats via coronary artery ligation.
  • Rats received either 3.6 mg of SPE or saline (control) via nasogastric tube.
  • Serum TNF-α levels and myocardial expression of TNF-α and ADAM17 were assessed on days 1, 4, 7, and 14 post-treatment.

Main Results:

  • SPE administration significantly reduced serum TNF-α levels starting from day 4 compared to the control group.
  • A notable decrease in ADAM17 expression was observed in the SPE-treated group.
  • TNF-α expression was localized to the myocardial membrane in rats treated with SPE.

Conclusions:

  • Syzygium polyanthum extract demonstrates anti-inflammatory effects in an MI rat model.
  • SPE appears to exert its benefits by downregulating ADAM17 expression, leading to reduced TNF-α levels.
  • This study supports the traditional use of Syzygium polyanthum for managing inflammatory conditions like MI.

Related Concept Videos